Toronto-based
Aleafia Health Inc.(TSX-V.ALEF,
OTCQX: ALEAF,
Forum) reported Q1 results on Wednesday, recording $6.4 million of positive adjusted EBITDA on $13.7 million in revenue.
The company is now just a handful of Canadian cannabis producers that has demonstrated consistent positive cash flow in its business. Aleafia also announced it has about $35 million in cash on its balance sheet and a production cost of $0.35 per gram, an industry low.
Aleafia is also managing its operations during the COVID-19 pandemic by conducting its medical cannabis consultations virtually, and introduced a delivery service to its patients.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.